BioNTech

1. Identify patients at high risk of recurrence.

2. Develop individualized mRNA cancer immunotherapy.

3. Administer the immunotherapy after surgery and chemotherapy.

4. Monitor the patient for recurrence.

1. Characterize the tumor microenvironment.

2. Administer BNT327 immunomodulator to target PD-L1 and VEGF-A.

3. Monitor tumor response and adjust treatment accordingly.

1. Identify the pathogen and its key antigens.

2. Design and formulate an mRNA vaccine.

3. Conduct clinical trials to evaluate safety and efficacy.

4. Manufacture and distribute the vaccine.

1. Perform genomic sequencing of the patient's tumor.

2. Identify tumor-specific neoantigens.

3. Design and manufacture a personalized mRNA vaccine.

4. Administer the vaccine and monitor immune response.

1. Identify conserved antigens across different strains.

2. Design an mRNA vaccine targeting these antigens.

3. Conduct preclinical and clinical studies to evaluate protection.

4. Manufacture and distribute the vaccine.